Back
Biogen Stock Predictions
Sponsored
BIIB
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
50
BIIB
Biogen
Last Price:
219.72
Seasonality Move:
6.6%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Biogen Stock Forecast
- Over the next 52 weeks, Biogen has on average historically risen by 37.7% based on the past 32 years of stock performance.
- Biogen has risen higher in 21 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 65.63%
-
Is Biogen Stock Undervalued?
The current Biogen [BIIB] share price is $219.04. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Biogen Stock Go Up Next Year?
- Over the next 52 weeks, Biogen has on average historically risen by 37.7% based on the past 32 years of stock performance.
Biogen Stock Rating
Sell
50
Biogen (BIIB)
is a Sell
Is Biogen overpriced?
- Biogen has risen higher in 21 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 65.63%
Biogen Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
319.76
52-Week Low:
189.44
Prediction Charts
Market Cap:
31.89B
Price in USD:
219.04
Volume:
974.82K
Beta:
0.94
Technical Analysis
SMA50:
212.02
SMA100:
228.91
SMA200:
241.21
52-Wk Change:
-31.13%
Stock Predictions
-
Is Biogen stock public?
Yes, Biogen is a publicly traded company. -
What is the Biogen stock quote today?
The Biogen stock price is 219.04 USD today. -
How to buy Biogen stock online?
You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-18 | 191.75 | 190.45 | 192.56 | 189.52 |
Apr-19 | 190.72 | 194.44 | 194.53 | 189.44 |
Apr-22 | 196.19 | 194.23 | 196.78 | 193.23 |
Apr-23 | 193.34 | 193.18 | 195.86 | 192.75 |
Apr-24 | 198.97 | 201.99 | 205.75 | 198.97 |
Apr-25 | 201.21 | 202.46 | 205.36 | 198.11 |
Apr-26 | 201.22 | 208.90 | 210.83 | 199.10 |
Apr-29 | 208.99 | 215.50 | 218.86 | 208.54 |
Apr-30 | 214.66 | 214.82 | 217.73 | 213.58 |
May-1 | 215.56 | 216.13 | 218.66 | 214.70 |
May-2 | 217.99 | 213.51 | 218.46 | 213.14 |
May-3 | 215.30 | 217.51 | 217.88 | 213.11 |
May-6 | 219.23 | 221.41 | 222.40 | 218.29 |
May-7 | 221.52 | 219.04 | 221.98 | 216.08 |
Biogen Earnings
Biogen Earnings Report: Per Share Biogen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen Forecast Revenue Growth
Biogen Stock Analysis: Historical quarterly revenues per share for Biogen and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $1.73 per share.
* Biogen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.